Overall rank by patents
#34,572
Across all tracked assignees
USPTO PatentsView assignee record - 7 granted patents across 7 technology areas, active 2024–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H04L (TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION).
The verdict
Bluescape holds 7 US patents across 7 technology areas, rank #34,572 of 50,000 tracked assignees.
Bluescape Buyer Llc has been granted 7 US utility patents between 2024 and 2025, placing Bluescape Buyer Llc at rank #34,572 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.0 claims per patent with primary concentration in H04L (TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION). As a US Corporation, Bluescape Buyer Llc is one of the more focused assignees in the PatentsView dataset. By volume, Bluescape sits between Blue Spark Energy Inc. (7 patents, rank #34,568) and Bone Solutions, Inc. (7 patents, rank #34,576) - the closest US assignees by grant volume. The composite Innovation Score of 35.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2024 through 2025, with 7 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Bluescape Buyer Llc's 20.0 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 7 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Bluescape Buyer Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Blue Spark Energy Inc.
7 patents
Blue Square Manufacturing, LLC
7 patents
Blue Tees Enterprises, LLC
7 patents
BlueMorph, LLC
7 patents
Bode Chemie GmbH
7 patents
Bolan Home Fashion GmbH
7 patents
Bolt Biotherapeutics, Inc.
7 patents
Bone Solutions, Inc.
7 patents
Bluescape Buyer LLC
7 patents
What this shows Bluescape holds 7 patents at rank #34,572, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #34,572 in granted patent volume.
Other assignees with the most granted patents in Bluescape's primary technology class.
Bluescape's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
35 Top 50% higher than 50% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2024 | 1 | 14.3% |
| 2025 | 6 | 85.7% |
Top 7 of 7 technology areas
Overall rank by patents
#34,572
Across all tracked assignees
35.2 out of 100
How to use this portfolio
Bluescape's 7 grants land it in the top 50% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.